527 related articles for article (PubMed ID: 23503512)
1. Senescent cells and their secretory phenotype as targets for cancer therapy.
Velarde MC; Demaria M; Campisi J
Interdiscip Top Gerontol; 2013; 38():17-27. PubMed ID: 23503512
[TBL] [Abstract][Full Text] [Related]
2. Cellular Senescence: The Sought or the Unwanted?
Sun Y; Coppé JP; Lam EW
Trends Mol Med; 2018 Oct; 24(10):871-885. PubMed ID: 30153969
[TBL] [Abstract][Full Text] [Related]
3. Keeping the senescence secretome under control: Molecular reins on the senescence-associated secretory phenotype.
Malaquin N; Martinez A; Rodier F
Exp Gerontol; 2016 Sep; 82():39-49. PubMed ID: 27235851
[TBL] [Abstract][Full Text] [Related]
4. Senescent cells in cancer therapy: why and how to remove them.
Zhang JW; Zhang D; Yu BP
Cancer Lett; 2021 Nov; 520():68-79. PubMed ID: 34237406
[TBL] [Abstract][Full Text] [Related]
5. Overcoming the senescence-associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer.
Chambers CR; Ritchie S; Pereira BA; Timpson P
Mol Oncol; 2021 Dec; 15(12):3242-3255. PubMed ID: 34137158
[TBL] [Abstract][Full Text] [Related]
6. Effects of senescence on the tumour microenvironment and response to therapy.
Reynolds LE; Maallin S; Haston S; Martinez-Barbera JP; Hodivala-Dilke KM; Pedrosa AR
FEBS J; 2024 Jun; 291(11):2306-2319. PubMed ID: 37873605
[TBL] [Abstract][Full Text] [Related]
7. The role of cellular senescence and SASP in tumour microenvironment.
Takasugi M; Yoshida Y; Hara E; Ohtani N
FEBS J; 2023 Mar; 290(5):1348-1361. PubMed ID: 35106956
[TBL] [Abstract][Full Text] [Related]
8. Senescence of Tumor Cells in Anticancer Therapy-Beneficial and Detrimental Effects.
Piskorz WM; Cechowska-Pasko M
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232388
[TBL] [Abstract][Full Text] [Related]
9. Exosomes as Emerging Pro-Tumorigenic Mediators of the Senescence-Associated Secretory Phenotype.
Jakhar R; Crasta K
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137607
[TBL] [Abstract][Full Text] [Related]
10. Senescence in polyploid giant cancer cells: A road that leads to chemoresistance.
Bharadwaj D; Mandal M
Cytokine Growth Factor Rev; 2020 Apr; 52():68-75. PubMed ID: 31780423
[TBL] [Abstract][Full Text] [Related]
11. Targeting senescent cells to reshape the tumor microenvironment and improve anticancer efficacy.
Jiang B; Zhang W; Zhang X; Sun Y
Semin Cancer Biol; 2024 Jun; 101():58-73. PubMed ID: 38810814
[TBL] [Abstract][Full Text] [Related]
12. Cellular senescence and the tumour microenvironment.
Takasugi M; Yoshida Y; Ohtani N
Mol Oncol; 2022 Sep; 16(18):3333-3351. PubMed ID: 35674109
[TBL] [Abstract][Full Text] [Related]
13. Biological functions of therapy-induced senescence in cancer.
Fitsiou E; Soto-Gamez A; Demaria M
Semin Cancer Biol; 2022 Jun; 81():5-13. PubMed ID: 33775830
[TBL] [Abstract][Full Text] [Related]
14. Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype.
Coppé JP; Rodier F; Patil CK; Freund A; Desprez PY; Campisi J
J Biol Chem; 2011 Oct; 286(42):36396-403. PubMed ID: 21880712
[TBL] [Abstract][Full Text] [Related]
15. Targeting cellular senescence: A promising approach in respiratory diseases.
Sugimoto M
Geriatr Gerontol Int; 2024 Mar; 24 Suppl 1():60-66. PubMed ID: 37604771
[TBL] [Abstract][Full Text] [Related]
16. Cellular senescence and the senescent secretory phenotype: therapeutic opportunities.
Tchkonia T; Zhu Y; van Deursen J; Campisi J; Kirkland JL
J Clin Invest; 2013 Mar; 123(3):966-72. PubMed ID: 23454759
[TBL] [Abstract][Full Text] [Related]
17. The role of senescence in cancer development.
Mavrogonatou E; Pratsinis H; Kletsas D
Semin Cancer Biol; 2020 May; 62():182-191. PubMed ID: 31260734
[TBL] [Abstract][Full Text] [Related]
18. Targeting cellular senescence in cancer and aging: roles of p53 and its isoforms.
Beck J; Turnquist C; Horikawa I; Harris C
Carcinogenesis; 2020 Aug; 41(8):1017-1029. PubMed ID: 32619002
[TBL] [Abstract][Full Text] [Related]
19. Cellular senescence in cancer.
Kim YH; Park TJ
BMB Rep; 2019 Jan; 52(1):42-46. PubMed ID: 30526772
[TBL] [Abstract][Full Text] [Related]
20. Impact of senescence-associated secretory phenotype and its potential as a therapeutic target for senescence-associated diseases.
Watanabe S; Kawamoto S; Ohtani N; Hara E
Cancer Sci; 2017 Apr; 108(4):563-569. PubMed ID: 28165648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
